Bulletin of the World Health Organization

Recent news from WHO

  • Governments, donors and international agencies, at a meeting in Geneva on 28 February, agreed that implementation of innovative, tailored approaches can eradicate the polio virus in Afghanistan, India, Nigeria and Pakistan, the only countries where polio remains endemic. Personal envoys of heads of the four governments presented these new plans for the final assault on these last remaining strongholds of the virus. WHO warned that if additional funds of US$ 575 million are not found for 2007–2008, the global polio eradication programme will be forced to cancel key activities as early as May 2007. Volunteers in Pakistan are trained at a polio clinic to administer the oral vaccine to children in refugee camps. Pakistan is one of the four remaining polio endemic countries. WHO/J M Giboux
  • A new WHO report shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders: public health challenges, which was released on 27 February, reveals that of the one billion people affected 50 million suffer from epilepsy and 24 million from Alzheimer and other dementias. Read the report at: http://www.who.int/mental_health/en
  • A new WHO report shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide. Neurological disorders: public health challenges, which was released on 27 February, reveals that of the one billion people affected 50 million suffer from epilepsy and 24 million from Alzheimer and other dementias. Read the report at: http://www.who.int/mental_health/en Rotary International President Bill Boyd, Director of US Centers for Disease Control and Prevention (CDC) Dr Julie Gerberding, UNICEF Deputy Executive Director Kul Gautam and WHO Director-General Dr Margaret Chan at 28 February meeting in Geneva. WHO
  • A meeting of experts held 14 to 16 February at WHO to discuss advances in pandemic influenza vaccine development, reported encouraging progress. More than 40 clinical trials have been completed or are ongoing. Sixteen manufacturers from 10 countries are developing prototype pandemic influenza vaccines to protect humans against H5N1 avian influenza virus. Five of them are also involved in the development of vaccines against other avian viruses (H9N2, H5N2, and H5N3). Researcher developing a vaccine candidate for avian flu in the United Kingdom. WHO/G Smyth

For more about these and other WHO news items please see: http://www.who.int/mediacentre/events/2007/en/index.html

Share